Earnings ·
Myomo, Inc. reported financial results for the second quarter ended June 30, 2026, announcing revenue of $11.7…
MYOMyomo, Inc.
Myomo, Inc. reported financial results for the second quarter ended June 30, 2026, announcing revenue of $11.7 million, a 21% increase year-over-year. The company raised its full-year revenue guidance to $45-47 million and expects third-quarter revenue between $11.5 million and $12.0 million. Second-quarter gross margin expanded to 72.1%, up from 62.7%, while operating expenses remained roughly flat, resulting in an adjusted EBITDA loss of $0.8 million compared to a $4.0 million loss in the prior year period. Net loss was $4.0 million, or $0.09 per share. The company operates in the wearable medical robotics industry, developing devices like the MyoPro to restore arm and hand function for patients with neurological disorders.